Latest news with #TipRanks
Business Insider
an hour ago
- Business
- Business Insider
Prestige Estates Projects Limited (PRESTIGE) Gets a Buy from UBS
In a report released yesterday, Aditya Chandrasekar from UBS maintained a Buy rating on Prestige Estates Projects Limited (PRESTIGE – Research Report), with a price target of INR1,725.00. The company's shares closed yesterday at INR1,466.60. Confident Investing Starts Here: According to TipRanks, Chandrasekar is a 2-star analyst with an average return of 22.5% and a 100.00% success rate. Chandrasekar covers the Real Estate sector, focusing on stocks such as Prestige Estates Projects Limited, DLF Limited, and Oberoi Realty Limited. Currently, the analyst consensus on Prestige Estates Projects Limited is a Moderate Buy with an average price target of INR1,825.00, representing a 24.44% upside. In a report released today, Jefferies also maintained a Buy rating on the stock with a INR1,700.00 price target. Based on Prestige Estates Projects Limited's latest earnings release for the quarter ending June 30, the company reported a quarterly revenue of INR20.25 billion and a net profit of INR2.33 billion. In comparison, last year the company earned a revenue of INR16.81 billion and had a net profit of INR2.67 billion
Business Insider
an hour ago
- Business
- Business Insider
J.P. Morgan Remains a Buy on Vishal Mega Mart Ltd. (VMM)
In a report released today, Latika Chopra from J.P. Morgan maintained a Buy rating on Vishal Mega Mart Ltd. (VMM – Research Report), with a price target of INR133.00. The company's shares closed yesterday at INR124.60. Confident Investing Starts Here: According to TipRanks, Chopra is a 2-star analyst with an average return of 0.7% and a 64.29% success rate. Chopra covers the Consumer Goods sector, focusing on stocks such as Dabur India Limited, Godrej Consumer Products Limited, and Asian Paints Ltd.. Vishal Mega Mart Ltd. has an analyst consensus of Moderate Buy, with a price target consensus of INR125.00.
Business Insider
2 hours ago
- Business
- Business Insider
UBS Sticks to Their Buy Rating for Akeso, Inc. (9926)
UBS analyst Chen Chen maintained a Buy rating on Akeso, Inc. (9926 – Research Report) yesterday and set a price target of HK$112.10. The company's shares closed yesterday at HK$83.80. Confident Investing Starts Here: Chen covers the Healthcare sector, focusing on stocks such as RemeGen Co. Ltd. Class H, Hangzhou Tigermed Consulting Co., Ltd. Class H, and Akeso, Inc.. According to TipRanks, Chen has an average return of 54.7% and a 78.57% success rate on recommended stocks. Currently, the analyst consensus on Akeso, Inc. is a Strong Buy with an average price target of HK$103.71, which is a 23.76% upside from current levels. In a report released yesterday, Morgan Stanley also maintained a Buy rating on the stock with a HK$87.00 price target.
Business Insider
2 hours ago
- Business
- Business Insider
Deutsche Bank Sticks to Their Buy Rating for EDreams ODIGEO (0QS9)
Deutsche Bank analyst Nizla Naizer maintained a Buy rating on EDreams ODIGEO (0QS9 – Research Report) yesterday and set a price target of €11.50. The company's shares closed yesterday at €7.83. Confident Investing Starts Here: Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter According to TipRanks, Naizer is a 5-star analyst with an average return of 17.3% and a 45.95% success rate. Naizer covers the Consumer Cyclical sector, focusing on stocks such as HelloFresh SE, AUTO1 Group SE, and Stroeer SE & Co. KGaA. The word on The Street in general, suggests a Moderate Buy analyst consensus rating for EDreams ODIGEO with a €10.22 average price target, which is a 30.52% upside from current levels. In a report released yesterday, Barclays also maintained a Buy rating on the stock with a €12.00 price target.
Business Insider
2 hours ago
- Business
- Business Insider
Barclays Remains a Buy on Sanofi (SNYNF)
Barclays analyst Emily Field maintained a Buy rating on Sanofi (SNYNF – Research Report) yesterday and set a price target of €125.00. The company's shares closed yesterday at $99.97. Confident Investing Starts Here: Field covers the Healthcare sector, focusing on stocks such as GlaxoSmithKline, AstraZeneca, and Roche Holding AG. According to TipRanks, Field has an average return of -1.5% and a 39.02% success rate on recommended stocks. In addition to Barclays, Sanofi also received a Buy from Bank of America Securities's Sachin Jain in a report issued yesterday. However, on the same day, J.P. Morgan maintained a Hold rating on Sanofi (Other OTC: SNYNF).
